Welcome to the Research Institute of Internal Medicine
The research profile of the Institute is to combine clinical medicine and molecular biology to establish a bridge between bench and bedside. This is of utmost importance in order to exploit in clinical medicine the recent development in immunology, biochemistry and molecular biology with the ambitious aim to develop novel treatment modalities and new diagnostic tools. Our profile includes all phases of this research, ranging from characterization of inflammatory profiles in various patient populations and in vitro experiments in various cells and cell lines to experimental studies in animal models, including gene modified mice, and interventional proof of concept studies in various patient populations.
Read more about our research here
Research groups at RIIM
| Professor Pål Aukrust is leading the groups that focus on inflammatory and immunological research (group 1-4) | ![]() |
| Professor Per Morten Sandset is leading the groups that focus on thrombosis and haemostasis (groups 5 and 7) | ![]() |
|
|
|
| 1. Inflammatory and molecular mechanisms in atherosclerosis and related metabolic disorders Group leader: Bente Halvorsen |
![]() |
| 2. Immunological and molecular mechanisms in myocardial remodeling and heart failure Group leader: Arne Yndestad |
![]() |
| 3. Endocrinology, inflammation and cardiovascular disorders including the study of biomarkers Group leader: Thor Ueland |
![]() |
| 4. Immunopathogenic mechanisms in immunodeficiency and infectious disorders Group leader: Børre Fevang |
|
| 5. Platelet and coagulation: clinical and basic research Group leader: Pål André Holme |
![]() |
| 6. Functional genetics in primary sclerosing cholangitis Group leader: Tom Hemming Karlsen |
|
|
7. Coagulation factors: role in the development of thrombosis, inflammation and cancer. Group leader: Grethe Skretting |
![]() |
Latest publications
Research Inst. for Internal Medicine
Thioredoxin Interacting Protein Is a Potential Regulator of Glucose and Energy Homeostasis in Endogenous Cushing's Syndrome
PLoS One, 8 (5), e64247
PubMed 23691179
Local inhibition of ornithine decarboxylase reduces vascular stenosis in a murine model of carotid injury
Int J Cardiol (in press)
PubMed 23680596
Evidence for long term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma
Leuk Lymphoma (in press)
PubMed 23656198













Print this page
